L.A.M. PHA. 3,75$ !!!! und hier 2,70 ? - 500 Beiträge pro Seite

[financeX]

L.A.M. PHA. 3,75$ !!!! und hier 2,70 ?

Bin gerade zu 2,75 eingestiegen nachdem ich gesehen habe das in den USA in den Boards, Chats und Newschannels schon Kurse von 3,75 Dollar und mehr gehandelt werden





fX

[donnerpower]

erster

[D.Balke [wO]]

Huh, werden die schon am Neuen Markt gehandelt?

Verschoben ins OTC

[asklepion]

Zulassung durch FDA heute bei Yahoo finance:

Related Quote
LAMP.OB 2.05 0.00
delayed 20 mins - disclaimer
Quote Data provided by Reuters



Thursday April 18, 7:01 am Eastern Time
Press Release
SOURCE: LAM Pharmaceutical, Corp.
Permission to Market LAM IPM(TM) Wound Gel Received From the FDA By LAM Pharmaceutical Corporation
LEWISTON, N.Y., April 18 /PRNewswire-FirstCall/ -- LAM Pharmaceutical, Corp. (OTC Bulletin Board: LAMP; FRANKFURT STOCK EXCHANGE: LAM; BERLIN: LAM), http://www.lampharm.com, is pleased to announce that the Company has received permission to market its proprietary, patented wound product -- LAM IPM(TM) Wound Gel*, pursuant to the Section 510(k), (FDA assigned number K020325). The letter from the FDA, the Department of Health & Human Services, Division of General, Restorative and Neurological Devices, Office of Device Evaluation, Centre for Devices and Radiological Health, was dated April 15, 2002 and was received by the Company on April 17, 2002.

LAM IPM(TM) Wound Gel has demonstrated in human trials an 88.0% rate of effectiveness in creating the necessary environment for wound healing of refractory (hard to heal) leg and foot ulcers. The incidence of these types of ulcers is increasing rapidly, as the baby boom generation ages and people live longer. Last year, 26 million ulcers were reported in the United States alone, of which approximately 6 million have been estimated as being chronic, difficult to heal and requiring thousands of dollars in total treatment costs.

Alan Drizen, Chief Executive Officer of LAM stated, ``I am most gratified to receive the permission to market LAM IPM(TM) Wound Gel, especially since it comes earlier than anticipated. While most important to LAM by itself, the approval of this significant product for sale sets the stage for commercialization of other major products in our portfolio.``

Joseph Slechta, LAM President and Chief Operating Officer added, ``Now that we have received permission to market our IPM(TM) wound product, we will immediately proceed with its introduction to market. The target date for the product launch has been set for June 3, 2002.``

``L.A.M. IPM(TM) WOUND GEL``

L.A.M. IPM(TM) Wound Gel is a clear, viscous, odorless, aqueous gel composed principally of sodium hyaluronate, a derivative salt of Hyaluronic acid.

Hyaluronic acid is a naturally occurring molecule found in various parts of the body. Hyaluronic acid used in L.A.M. IPM(TM) Wound Gel is derived from avian sources. The gel has demonstrated to be of value in the management of certain skin ulcers and wounds where maintaining a moist environment is supportive of the healing process. In human skin hyaluronic acid is involved in such important biological functions as tissue hydration and proteoglycan organization (formation of proteins and sugars).


INDICATIONS

For over-the-counter use
L.A.M. IPM(TM) Wound Gel is suitable for:
-- Minor abrasions
-- Minor cuts

Under the supervision of a healthcare professional.
L.A.M. IPM(TM) Wound Gel is suitable for exuding wounds such as
-- Leg ulcers
-- Pressure ulcers
-- Diabetic ulcers
-- Management of mechanically or surgically debrided wounds.

CONTRAINDICATIONS


Do not administer to patients with known hyper-sensitivity to this product or to avian proteins.

WARNINGS

-- The prolonged use of the product may give rise to sensitization
phenomena. Should this occur, discontinue use of the product
immediately and consult a healthcare professional.
-- To prevent the possibility of cross infection, a tube of L.A.M.
IPM(TM) Wound Gel should be used on one patient only.
-- Direct contact with the wound and the container should be avoided.
-- Do not use in case of package damage.
-- Do not use the product after the expiry date noted on package.
-- Keep out of reach of children

PRECAUTIONS AND OBSERVATIONS

For over-the-counter use:
-- If the wound appears to get larger after the first three or four
applications, discontinue use and consult a healthcare professional.
-- Should you observe irritation, reddening, inflammation, maceration
(whitening of the skin), hyper granulation (excess tissue formation)
or sensitivity (allergic reaction), consult a healthcare
professional immediately.
-- Consult a healthcare professional if:
1. Signs of infection occur, increased pain, bleeding, wound
drainage.
2. There is a change in wound color and/or odor.
3. The wound does not begin to show signs of healing in a few
days.
4. Any other unexpected symptoms occur.
-- When using L.A.M. IPM(TM) Wound Gel in combination with other wound
care products, always consult a healthcare professional.

Under the supervision of healthcare professional:
-- The treatment of any leg ulcers, pressure ulcers, diabetic ulcers
and surgically debrided wounds should be under the supervision of a
healthcare professional.
-- Appropriate supportive measures should be taken where indicated
(e.g. use of graduated compression bandaging in the management of
venous leg ulcers or pressure relief measures in the management of
pressure ulcers).

NOTE: The control of blood glucose as well as appropriate pressure relief
measures should be provided with diabetic foot ulcers.

-- Colonization of chronic wounds is common and it is not a
contraindication to the use of L.A.M. IPM(TM) Wound Gel. The
dressing may be used on infected wounds under medical supervision
together with appropriate therapy and frequent monitoring of the
wound by the healthcare professional.

HOW TO USE

1. First clean the ulcer or other wound with normal saline solution
(other cleansing agents are not recommended). Normal saline
solution can be obtained through your local pharmacy.

NOTE: Debridement (surgical cleansing) of the wound may be performed at
the discretion of a healthcare professional.

2. Remove excess moisture with a dry gauze.

3. Apply L.A.M. IPM(TM) Wound Gel liberally into the cavity of the
ulcer or wound site and the surrounding area.

4. Apply a non-stick gauze dressing (Telfa(R) pad, Vaseline(R)
Petroleum Gauze or other suitable non-stick pad) over the wound
site.

NOTE: Once L.A.M. IPM(TM) Wound Gel is applied the gel should not be
touched.

5. Finally, wrap a self-adhesive bandage over the non-stick gauze
dressing.

6. Repeat the entire process of wound cleansing, applying L.A.M.
IPM(TM) Wound Gel and bandaging daily.

7. Visit a healthcare professional as recommended.

STORAGE


Store in a cool, dry place at room temperature. Temperature should not exceed 35 degrees C/95 degrees F. Protect from freezing.

FURTHER INFORMATION

For further information, contact:
L.A.M. Pharmaceutical, Corp.,
Professional Services Department
755 Center Street, Unit 5
Lewiston N.Y. 14092
1-877-526-7717 or [phone].
http://www.lampharm.com

In case of an emergency contact your healthcare professional.


Telfa® is a registered trademark of Tyco Health Care Group, L.P.

Vaseline® is a registered trademark of Cheseborough-Pond`s, Inc.

IPM(TM) and Ionic Polymer Matrix(TM) are trademarks of L.A.M. Pharmaceutical, Corp.

L.A.M. IPM(TM) Wound Gel is protected by one or more of the following patents: 5,897,880; 6,120,804; 6,007,843; 6,063,405.

About LAM Pharmaceutical, Corp.

LAM Pharmaceutical, Corp. is a biomedical company with laboratories in Lewiston, New York, and a business office in Toronto. LAM focuses on the development and commercialization of novel wound healing and transdermal drug delivery systems that offer patients, among other benefits, safer and more effective treatment for a variety of serious diseases. The technology is based on an original Ionic Polymer Matrix(TM) technology (IPM(TM)), a proprietary and patented combination (a total of ten U.S. issued and approved patents) of electrically charged and non-charged molecules with wound-healing properties. IPM(TM) technology is also appropriate for use with well-established drugs, allowing for the sustained delivery of greater amounts to the target areas than is otherwise possible by oral means, thus prolonging therapeutic activity.

The main ingredient of the Ionic Polymer Matrix(TM) technology is a derivative of hyaluronic acid, a molecule normally found in the skin, joints and bones. Hyaluronic acid is a non-immunogenic (the body does not react to it) and it is involved in such important biological functions as tissue hydration and proteoglycan organization (formation of proteins and sugars) to optimize tissue repair and prevent tissue aging. As well, hyaluronic acid is present in high concentrations in fetal skin where wound healing is rapid and leaves little scarring.

LAM IPM(TM) Wound Gel is a clear, viscous, aqueous, odorless gel composed principally of sodium hyaluronate, a derivative salt of Hyaluronic acid. LAM IPM(TM) Wound Gel has demonstrated in both human and animal trials to be of significant value in the management of certain skin ulcers and wounds where maintaining a moist environment is supportive of the healing process. In human skin, Hyaluronic acid is involved in such important biological functions as tissue hydration and proteoglycan organization (formation of proteins and sugars).
As of April 1, 2002, LAM had ten issued and allowed patents in the United States. LAM IPM(TM) Wound Gel is protected by one or more of the following patents: 5,887,880; 6,120,804; 6,007,843; 6,063,405. All referenced patents have been issued to LAM Pharmaceutical, Corp. by the United States Patent Office and have subsequently been filed on a global basis or are in the process of global filing.

The Company`s list of products under development include the following:

LAM IPM(TM) - Post Surgical Gel -- An advanced IPM(TM) (ionic polymer matrix) designed for use on fresh surgical wounds (stapled or sutured) for the purpose of creating an environment conducive to improved healing.

LAM IPM(TM) - Extreme Dry Skin Formula -- A gel formula designed to saturate the stratum corneum, to relieve the symptoms of eczema, dermatitis and extremely dry skin.

LAM IPM(TM) - Female Sexual Dysfunction Matrix -- a product that provides enhanced lubrication while also allowing the external structures of the female genitalia to be flushed with greater blood supply.

LAM IPM(TM) - Motion Sickness Matrix -- a product currently under development, which is a topically applied delivery system, using a patch, of a well-known motion sickness drug.

LAM IPM(TM) - Arthritic Pain Matrix -- is a clear aqueous gel that contains a well proven off patent drug.

For more information please visit our website at http://www.lampharm.com or send us an e-mail at [e-mail] to receive the latest information and press releases.

Statements in this press release regarding our business which are not historical facts are ``forward-looking statements`` that involve risks and uncertainties which could cause the Company`s actual results and financial condition to differ materially from those anticipated by the forward-looking statements. These risks and uncertainties include, but are not limited to uncertainties relating to the need for additional funds and corporate partners, product liability, dependence on third parties for manufacturing and marketing, the early stage of products being marketed or under development, patent risk and competition.

Company Contact: Anthony Vespa
Toll Free in N. America (877) LAM-7717
[phone]
Tel [phone]
Fax [phone]
Website: http://www.lampharm.com

Press Contact: Barry S. Kaplan
Barry Kaplan Associates
[phone]
FAX [phone]
Email: [e-mail]

SOURCE: LAM Pharmaceutical, Corp.


Email this story - Most-emailed articles - Most-viewed articles

[Lumolino]

kann bitte jemand sagen wo die vorborslichen Kurse von LAMP an der OTCCB zu sehen sind?
D A N K E

[donnerpower]

Da Haben ja heute die Amis mal schön wieder bei uns eingekauft!

[MAT@DOR]

Es gibt an der OTCBB keine vorbörslichen Kurse. Allenfalls taxen die Marketmaker hoch und runter und schieben ein paar Pakete hin und her.

[TradingExperte]

aktuell ask / bid bei 2,60 DOLLAR !!!!!!!!!!


Tendenz steigend

[TradingExperte]

FRT STREAM das ist die Adresse wo du aktuelle Kurse sehen kannst

[Volvic_Zitrone]

Will da jemand die SLs abräumen oder geht`s wirklich runter?

[biketraum]

Denke, das Zweitere. Hoffe , Du bist nicht mehr investiert.

[yxcv1234]

Kurs erholt sich wieder - Rally kann weitergegen !

[zockilowski]

@ Tradingexperte
Du Doof - und ich fall auch noch drauf rein !

[donnerpower]

Die Amis nehmen logischerweise jetzt Gewinne mit(gestern noch bei 1,37$ nicht vergessen),es wird heut noch mehr runter gehen,
aber zum Abend nach 20Uhr müsste es dann nochmals kräftig hoch gehn

[alex1975]

so wie ich das sehe geht es doch schon wieder hoch

[yxcv1234]

und wer hat nun die akt. Kurse von USA. Wo wird LAMP getaxt ?

[donnerpower]

Wie gesagt aufpassen es ist ein OTCBB-Wert!!!

Akt. Steigend,aber hier sind viele die noch raus wolln!

[yxcv1234]

wieso raus wollen.

ich dachte hier gibts nur "mutige" anleger, die eine 4 vor dem Komma sehen wollen ?

[jumanii]

,...es hilft nichts, bin bei 2,2 $ raus, es kommen lauter
10-50 er packete!!!

mfg

[donnerpower]

Nur Geduld haben,

NOCHMALS DAS IST EIN OTCBB-WERT,

[jumanii]

hä, donnnerpower lieber bei 1 $ verkuafen als über 2$?
mußt ja viel geld haben!

mfg

[donnerpower]

@yxcv1234

#14

[donnerpower]

@jumanii

Keine Angst habe mit Sicherheit schon längst
ein paar Teile beim hoch abgestossen,leider
nicht über 2,9!

gruss

[stsa]

@all
die MM´s sind jetzt fertig.

[jumanii]

innerhalb 8 min. sind 200000 shares verkauft worden, große
packete, ned schlecht, ist jemand nicht so überzeugt!

mfg

[Apetitaeffchen]

Bin mir sicher, die hat auch jemand gekauft.

[BlackAngel]

@jumanii

mmmhh bei steigendem Kurs. Da scheint ja jemand ganz schön überzeugt sein.

[BIG_BLOCK]

L.A.M. PHARMACEUTICAL CORP (LAMP)
04/18/2002 10:42:36 Eastern Time
Exchange OTC BB Volume 1311000
Last 1.8000 Change -0.2500
Bid 1.8000 Bidsize 5
Ask 1.8100 Asksize 5
High 2.5000 Low 1.7500

[somart]

Sell on good news. Wir werden heute noch unter 1,5 Dollar gehen.

[BlackAngel]

Ach da ist ja wieder mein spezieller Freund. Für dich bin ich sogar 1,6 $ Bid.

Gruß blacky